Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial-Reference-Cited by-同舟云学术

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

Published:2011-12 Issue:9808 Volume:378 Page:2013-2020
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Heart Protection Study Collaborative Group

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience;Eur Heart J,1999

2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002

3. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial;BMC Med,2005

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010

5. Report of the conference on low blood cholesterol: mortality associations;Jacobs;Circulation,1992

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term statin use and risk of cancers: a target trial emulation study;Journal of Clinical Epidemiology;2024-08

2. Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis;Journal of Clinical Oncology;2024-07-20

3. A NATUrally Randomized trial Evaluating a vaccine-like strategy to lower LDL by inhibiting PCSK9 on the lifetime risk of major cardiovascular events (NATURE-PCSK9);2024-07-01

4. Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study;International Journal of Clinical Pharmacy;2024-05-16

5. Current and Future Treatments of Vascular Cognitive Impairment;Stroke;2024-04